RBB Bancorp (RBB) Q3 2026 Earnings Call Transcript

RBB Bancorp reported third-quarter net income of $12.6 million, up 25% sequentially, and diluted EPS of $0.74 versus $0.59 in the prior quarter; results included a $2.7 million pretax Brooklyn office sale gain that added about $0.12 per share. Net interest income rose 6% to $31.8 million, net interest margin expanded 10 basis points, and loans held for investment grew $89.8 million, or 10.8% annualized. Nonperforming assets fell 11.3% to $38.7 million, while retail deposit growth enabled wholesale deposits to decline $58.7 million to less than 2% of deposits; management expects quarterly noninterest expense of about $19 million but cited near-term pressure on funding costs.

Analysis

RBB’s earnings-quality mix matters more than the headline beat: the Brooklyn sale, nonaccrual recoveries and an FHLB dividend contributed to reported results, while underlying loan growth and repricing provide a plausible recurring offset. The key near-term asymmetry is timing: deposit costs can reset quickly in a competitive market, while only part of the variable-rate book reprices over the coming year. A reported margin expansion therefore does not yet establish durable spread widening.

The improved funding mix reduces wholesale-funding sensitivity, but a roughly 100% loan-to-deposit ratio leaves less room to grow without attracting deposits or selling loans. Loan sales can relieve that constraint but may dilute reported growth and produce uncertain gains. The San Francisco production office and planned commercial mix shift are potential medium-term earnings drivers, not yet proven contributors at scale.

Credit improvement is constructive, but the remaining large REO exit is a discrete 1H27 catalyst: a delayed sale or proceeds below carrying value could reverse some of the confidence from declining NPAs. Rising special-mention loans also warrant monitoring alongside the small reported charge-off figure. Capital strength supports repurchases, yet aggressive returns could compete with funding needs if deposit pricing pressures persist.

Contrarian view: the quarter may look cleaner than normalized earnings because several favorable items coincided; conversely, a strong capital position and eventual loan repricing could be underappreciated if funding costs stabilize. The transcript contains conflicting NIM and origination-yield figures; verify against the filing before updating estimates.

Key Decisions for Investors

• Avoid chasing the reported EPS step-up. Reassess after the next filing using earnings ex-building gain and a margin bridge that separates recoveries and the FHLB dividend from recurring spread income.
• Keep RBB on a conditional long/watch list rather than initiating on this transcript alone. Consider a small long only if core NIM holds above 3% and deposit costs stabilize; hedge broad bank exposure with KRE if the thesis is company-specific.
• Track deposit pricing, loan-to-deposit ratio, loan-sale volume and commercial originations over the next 1–3 months. A sustained rise in funding costs without offsetting asset repricing would falsify the margin-improvement thesis.
• Treat the REO disposition as a 1H27 catalyst, not a base-case gain: monitor sale timing and proceeds versus carrying value. A delay or impairment would weaken the credit-recovery case.